Analyzing the clinical characteristics of the SCAMP5 gene in gliomas and establishing a predictive model

Gliomas are frequently occurring tumors in the nervous system. The secretory carrier membrane protein 5 (SCAMP5) plays a distinct role in the cytosolic function of mammalian cells and is associated with different neurological disorders. However, how SCAMP5 is expressed and its prognostic value in gliomas is unclear. The datasets were downloaded from the Chinese Glioma Genome Atlas website (http://www.cgga.org.cn/). We conducted a Cox survival analysis to establish a correlation between SCAMP5 gene expression and the general survival rate of patients with glioma. We performed Gene Ontology analysis to determine the biological functions of the SCAMP5 gene. Finally, we constructed a prediction model using primary relapse state type, age, grade, isocitrate dehydrogenase mutation status, 1p/19q co-deletion status, and the SCAMP5 gene expression value. Using this model, we can forecast the survival rates of patients for 1, 2, 3, 5, and 10 years. SCAMP5 was enriched in low-grade gliomas and isocitrate dehydrogenase mutant gliomas, 1p19q-deficient gliomas. SCAPM5 is an independent prognostic factor for the overall survival of glioma patients. Predictive models developed by SCAMP5 were able to predict well the long-term survival of patients. The evidence suggests that the SCAMP5 gene plays a significant function in glioma patients. There is a clear correlation between the expression of the SCAMP5 gene and the overall survival of glioma patients.